Jennifer Schloss

发表

Development and Characterization of a Preclinical Model for the Evaluation of CD205-Mediated Antigen Delivery Therapeutics in Type 1 Diabetes

T. Keler, T. DiLorenzo, Li-Zhen He, 2019, ImmunoHorizons.

Improved Murine MHC-Deficient HLA Transgenic NOD Mouse Models for Type 1 Diabetes Therapy Development

C. Lutz, D. Roopenian, D. Serreze, 2018, Diabetes.

Neural lineage differentiation of embryonic stem cells within alginate microbeads.

N. Langrana, M. Yarmush, Uday Chippada, 2011, Biomaterials.

Glucagon‐reactive islet‐infiltrating CD8 T cells in NOD mice

T. DiLorenzo, Rodolfo J. Chaparro, G. Mukherjee, 2015, Immunology.

An HLA-Transgenic Mouse Model of Type 1 Diabetes That Incorporates the Reduced but Not Abolished Thymic Insulin Expression Seen in Patients

T. DiLorenzo, R. Ali, J. Babad, 2015, Journal of diabetes research.

Characterization of the peptide binding specificity of the HLA class I alleles B*38:01 and B*39:06

John Sidney, Alessandro Sette, Carrie Moore, 2016, Immunogenetics.

Characterization of the peptide binding specificity of the HLA class I alleles B*38:01 and B*39:06

J. Sidney, A. Sette, J. Shabanowitz, 2016, Immunogenetics.

HLA-B*39:06 Efficiently Mediates Type 1 Diabetes in a Mouse Model Incorporating Reduced Thymic Insulin Expression

D. Serreze, T. DiLorenzo, Jeremy J. Racine, 2018, The Journal of Immunology.

HLA-B*39:06 Efficiently Mediates Type 1 Diabetes in a Mouse Model Incorporating Reduced Thymic Insulin Expression1

D. Serreze, T. DiLorenzo, Jeremy J. Racine, 2018, bioRxiv.

Flow cytometric assessment of leukemia-associated monocytes in childhood B-cell acute lymphoblastic leukemia outcome

D. Teachey, W. Carroll, E. Raetz, 2023, Blood advances.